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Introduction
Cystic fibrosis (CF) is genetically determined illness,
which is caused by the mutation in the CFTR gene.
CFTR protein, product of CFTR expression, acts as a
cAMP dependent chloride channel in apical membrane
of cells of respiratory epithelium and excretory ducts
of glands. Defect of this ion channel in CF patients
leads to impairment of excretion of chloride ions, and
thus to retention of sodium and water absorption. As a
consequence of this cascade, the viscosity of intra-
bronchiolar mucus is increased. The lumen of bronchi
and internal organs is plugged by thick and dense
mucus. Moreover, CFTR is also located in membranes
separating cellular compartments. Impaired CFTR
function can potentially alter enzyme activity in cells.
The digestion of food begins in oral cavity. The
saliva provides proper, liquid environment for various
biochemical processes.  Among different enzymes,
saliva contains hydrolases, including cathepsin D
(CTSD, EC 3.4.23.5). 
Cathepsin D is one of the proteolitic cascade
enzymes. Physiological wearing out and  decomposi-
tion of various tissues and cells result in occurrence of
trace quantities of this enzyme in serum and body flu-
ids, including saliva. Significant intensification of the
damage and increase in CTSD activity in the blood
takes place in certain pathological conditions such as
breast cancer or uterine leiomyomas. According to the
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literature, elevated cathepsin D concentration and
activity promotes in vitro the adhesion of Pseu-
domonas aeruginosa to corneal cells [15]. The aim of
this study was to determine  cathepsin D activity in
mixed saliva in cystic fibrosis patients and healthy
controls.    
Materials and methods
Saliva. The study was performed in a group of 26 CF patients (10F,
16M). Clinical diagnosis of cystic fibrosis was confirmed by
molecular examination of CFTR gene.  The results obtained in CF
group was compared with the results of thirty healthy subjects
(12F, 14M). Clinical characteristics of both groups is showed in
Table 1.  Collection of mixed saliva were secured by standardized
technique. From each subject 8 ml of mixed saliva was obtained.
Then subjects chewed on 1.5 × 1.5 × 1.5 cm paraffin pledgets  for
2 min. For next two minutes the mouth was rinsed with tap water
to remove any residual paraffin and saliva. Then saliva was col-
lected for the second time. The material was collected to sterile
test-tubes and stored in -80°C until analysis. 
Proteins and glycoproteins. Protein and glycoprotein content
was assessed using Winzler's method [4]. Proteins and glycopro-
teins differ in solubility. Proteins in saliva were precipitated in
reaction with chloric acid (VII). Glycoproteins in supernatant were
precipitated with phosphorovolframic acid. 
To 0.5 ml of whole saliva, 4.5 ml of 0.15 mol/L NaCl solution
and 2.5 ml of 1,8 mol/L HClO4 The samples were incubated in
room temperature for 10 min, then centrifugation was performed
(at 4°C, 3000 rpm for 10 min). Supernatant was collected for gly-
coproteins measurement. Supernatant was dissolved in 1 ml of
10% Na2CO3, 3.5 ml H2O and 0.5 ml of a Folin-Ciocalteau
reagent. Samples were left for dying for additional 30 min.  The
absorbance was assessed at wave length of 750 nm. Protein con-
centration (C) was counted according to the following equation
C=A*F (A - absorbance; F - calibration coefficient =4.62).
To 5 ml of supernatant, 1 ml of 5% phosphorovolframic acid
was added. Samples were left for precipitation for 10 min, then
were centrifuged (at 4°C, 3000 rpm for 10 min). After centrifuga-
tion supernatant was discarded and sediment was dissolved in 1 ml
of 10% Na2CO3, 3.5 ml H2O and 0.5 ml of Folin-Ciocalteau
reagent. Samples were dyed after 30 min.  The absorbance was
assessed at wave length of 750 nm.  The absorbance was measured
at wave length of 750 nm. Glycoprotein concentration (C) was cal-
culated according to following  equation C=Tyr*F (Tyr - tyrosine
concentration in mg/ml; A - absorbance × 800 = Tyr nmol/ml; F -
calibration coefficient = 23.8).
Cathepsin D. The activity of CTSD was measured according to
the following protocol. To 0.4 ml of saliva 0.1 ml of 6% hemoglo-
bin (Disco Laboratories, Detroit, USA), denaturated with
hydrochloric acid, was added and incubated for 6 h in 37°C.  Reac-
tion was conducted in pH=3.5 and terminated with 0.5 ml of 10%
trichloracetic acid. After centrifugation (1500 g, 4 min, 0°C) the
amount of released tyrosine was measured using the Folin-Ciocal-
teau method in the cupric modification [11]. Afterwards to 0.250
ml of supernatant 1.5 ml of cupric reagent was added (30 ml of
10% Na2CO3 and 1 ml of 0.5% CuSO4 in 1% sodium citrate). After
additional 10 min 0.250 ml of Folin-Ciocalteau reagent was added.
The absorbance was measured after 30 min of incubation at wave
length of 750 nm. The amount of released tyrosine was calculated
according to following equation: C=A*F ( C - tyrosine concentra-
tion in nmol/m, A - absorbance, F - calibration coefficient=800).
Ethical issues. The study was approved by the Local Bioethics
Committee of Medical University of Bialystok. Each patient
received detailed information about the aims and expected results
of study and gave an informed consent. 
Statistical analysis. Obtained results of enzymatic activity of both
proteolytic enzymes were expressed to protein content in each
specimen. The comparison of both studied and control group was
performed using student's t test. For the statistical calculation a
Sigma Stat 2.03 (SPSS Inc., Chicago, IL, USA) statistical package
was used.   
Results
Protein concentration
Protein concentration in controls and CF group before
stimulation of excretion was 1.15±0.714 mg/mL and
1.54±0.925 mg/mL. After stimulation protein concen-
tration in saliva has lowered to 0.88±0.77 mg/mL in
CF group and 1.24±1.213 mg/mL in controls. The
results in both groups are given in Table 2 and 3.
Protein concentration was significantly higher in CF
group than in controls (Fig. 1). After stimulation no
such difference was observed.
Glycoprotein concentration
Glycoprotein concentration in controls and in CF group
was respectively: before stimulation  1.08±0.271
mg/mL and 1.05±0.344 mg/mL; after stimulation
0.92±0.292 mg/mL and 0.86±0.283 mg/mL (Table 2
and 3). Differences in glycoprotein concentration before
and after stimulation of saliva excretion in both groups
were not statistically significant. 
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Table 1. Clinical characteristics of CF patients and controls.
Fig. 1. Protein and glycoprotein content in saliva samples collect-
ed before stimulation (b.s.) and after stimulation (a.s.); *p≤0.05.
Activity of cathepsin D (CTSD)
The activity of CTSD in controls was 45.9±24.98 Tyr
nmol/mL/4h before stimulation and 109.3±56.94 Tyr
nmol/mL/4h after stimulation of excretion. Observed
difference in CTSD activity before and after stimula-
tion was significant (Table 2). In CF group CTSD
activity before stimulation was 134.5±81.80 Tyr
nmol/mL/4h and after stimulation 134.4±62.18 Tyr
nmol/mL/4h. Comparing the CTSD activity in both
groups statistically significant difference has been
revealed in samples collected before stimulation of
excretion (p=0.013). After stimulation the CTSD
activity in both groups was similar (Fig. 2). The activ-
ity of cathepsin D expressed in nmol/1g of protein is
presented in Fig. 3.
Discussion
The saliva creates appropriate environment in mouth
for various physiologic processes. The composition of
saliva depends of many factors. In CF patients the
composition of saliva can be changed due to the pres-
ence of  CFTR protein in epithelial cells of excretory
ducts of salivary glands. Also the amount of saliva
produced by CF patients can be diminished causing the
symptoms of dry mouth and increasing the risk of den-
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Table 2. Biochemical characteristics of saliva in healthy controls before stimulation (b.s.) and after stimulation (a.s.).
Table 3. Biochemical characteristics of saliva in studied CF group before stimulation (b.s.) and after stimulation (a.s.).
Fig. 2. Cathepsin D (CTSD) in nmol/mL/6h in saliva of CF
patients and healthy controls before (b.s.) and after (a.s.) stimula-
tion of excretion with paraffin pledgets; *p≤0.05.
Fig. 3. Cathepsin D (CTSD) in nmol/1g of protein in saliva of CF
patients and healthy controls before (b.s.) and after (a.s.) stimula-
tion of excretion with paraffin pledgets; *p≤0.05.
tal caries [18]. CFTR is  also found in membranes sep-
arating intracellular compartments of different pH
[20]. Due to defective function of mutated CFTR,
more alkaline pH is observed in Golgi apparatus,
prelysosomes and endosomes. This causes the produc-
tion of proteins with lowered number of sialic acid
residues and increased number of sulphuric acid
residues.  Pseudomonas aeruginosa preferably adhere
to glycoproteins deprived of sialic acid residues, there-
fore in CF patients we can observe increased coloniza-
tion of lower respiratory tract with this pathogen. This
is an immense clinical problem in these patients.
Cathepsin D is a recognized marker for breast can-
cer [16]. Overexpression of cathepsin D in breast can-
cer cells is well documented. For diagnostic and mon-
itoring purposes cathepsin D levels can be measured in
saliva [17]. Cathepsin D is also an endopeptidase
found in lysosomes of all mammalian tissues. Primary
function of this enzyme is cleavage of peptic bonds,
but recently new interesting functions of it has been
described [19]. Cathepsin D can be an important regu-
lator of apoptosis acting as an direct activator of cas-
pase 3 and 9. It can also stimulate the release of
cytochrome c from mitochondrion and thus induce the
intrinsic apoptotic pathway. 
In this short communication we present our results
showing, that the activity of cathepsin D in saliva of
cystic fibrosis patient is significantly higher than in
healthy controls before the stimulation of excretion with
paraffin pledgets (Fig. 2). The difference is even more
visible if the activity of cathepsin D is expressed in
nmol per 1g of protein (Fig. 3). There is no data avail-
able concerning this problem in cystic fibrosis. Dong et
al. in their study on mouse corneal cells infected with P.
aeruginosa observed, that overexpression of cathepsins
B, D and L is present [15]. Furthermore, an increase in
CTSD mRNA was noted before mRNA for other
cathepsins. Cathepsin D can also be involved in pro-
longed inflammatory response in lung and excessive
apoptosis resulting in an activation of fibroblasts, and
subsequently the induction of tissue remodeling with
pulmonary fibrosis [21]. Our observations can be an
interesting start point for further studies.
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